Guopan Yu

10PUBLICATIONS
41CO-AUTHORS
NanomaterialsHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 18, 2026
Carrier-Free Berberine/Nitidine Chloride Self-Assembled Nanoparticles Induce Ferroptosis to Overcome Bortezomib Resistance in Multiple Myeloma.

|May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.

Yu Zhang, Zinan Feng, Jing Du

|May 21, 2025
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.

Yiling Ye, Xinyu Liu, Huajuan Dai

|Feb 12, 2025
Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia.

Yu Zhang, Zhao Yin, Zurong Yao

|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.

Guopan Yu, Yu Zhang, Sijian Yu

|Sep 05, 2024
Homoharringtonine sensitized resistant acute myeloid leukemia cells to venetoclax-induced apoptosis.

Zhao Yin, Ya Gao, Xiaoyin Bu

Pageof 2

Frequent Collaborators

7 joint publications

Qifa Liu

4 joint publications

Li Xuan

3 joint publications

Hua Jin

3 joint publications

Xuejie Jiang